Additional information
| Active substance | Dapagliflozin |
|---|---|
| Water Retention | Can cause some diuresis, generally does not cause significant water retention |
| Hepatotoxicity | No significant hepatic toxicity reported |
| Lab Test | Monitoring blood glucose levels and renal function tests are recommended |
| Strength | 5mg |
| Also known as | BMS-512148 |
| Blood pressure | Can modestly reduce blood pressure |
| Trade name | Farxiga, Xigduo XR (combination with metformin) |
| Storage conditions | Store at room temperature away from moisture and heat |
| Chemical name | (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol |
| Formula | C21H25ClO6 |
| Substance class | SGLT2 inhibitor |
| Main action | Reduces blood glucose by inhibiting sodium-glucose transport protein 2 in the kidneys |
| Half-life | Approximately 12.9 hours |
| Dosage (medical) | Typically 10 mg once daily |
| Dosage (sports) | Not applicable |
| Effects | Lowers blood sugar, aids in weight loss |
| Side effects | Risk of genital infections, urinary tract infections, possible dehydration, rare cases of diabetic ketoacidosis |
| Use in sports | Not typically used in sports |
| Manufacturer | AstraZeneca Pharma Ltd. |
| Packing | 14 tabs/blister |
Champix 56 tabs Pfizer
Rovamycine 3.000.000 iu Eczacibasi
Avory Pharma Oral Turinabol 10 mg 100 Kapseln
Prograf 1mg Astellas Pharma
FUCIDIN 500 mg Abdi Ibragim
Seretide Disckus (Advair) 500 mcg Glaxosmithkline
Januvia 100mg Merckgroup
Prograf 5mg Astellas Pharma
Norvacs 10 mg Pfizer 



Reviews
There are no reviews yet.